Employees with fibromyalgia: Medical comorbidity, healthcare costs, and work loss
Employees with fibromyalgia: Medical comorbidity, healthcare costs, and work loss
复制标题
DOI：
10.1097/jom.0b013e31815cff4b
复制
发表时间：
2008-01-01
影响因子：
3.2
通讯作者：
Robinson, Rebecca L.
中科院分区：
文献类型：
--
作者：
White, Leigh Ann;Birnbaum, Howard G.;Robinson, Rebecca L.
目的：比较2005年的卫生保健资源之间的匹配样本的雇员与纤维肌痛（FM），骨关节炎（OA），和控制。研究方法：使用索赔数据库的私人保险的个人，FM和OA样本来自那些有两个或两个以上的疾病特定的索赔在1999年至2005年（>= 1在2002年至2005年）。结果如下：FM患者的总成本（10，199美元）接近OA成本（10，861美元，P = 0.3758），显著高于对照组（5274美元，P < 0.0001）。费用构成因疾病而异（直接医疗：FM $7286 vs OA $8325，P < 0.0287;药房：FM $1630 vs OA $1341;间接：FM $2913 vs OA $2537，P < 0.0001）。患有FM的员工比OA有更多的精神病诊断，慢性疲劳和大多数疼痛状况。在这两个样本中，使用多种处方药类别是常见的。结论：FM造成了显著的经济负担。工作损失是造成这种影响的主要原因。
Objectives: To compare 2005 health care resources among matched samples of employees with fibromyalgia (FM), osteoarthritis (OA), and controls. Methods: Using a claims database of privately insured individuals, FM and OA samples were derived from those with two or more disease-specific claims in 1999 to 2005 (>= 1 in 2002 to 2005). Results: Total costs for employees with FM ($10,199) approached OA costs ($10,861, P = 0.3758) and were significantly higher than controls ($5274, P < 0.0001). Cost components varied across disease-specific samples (direct medical: FM $7286 vs OA $8325, P < 0.0287; pharmacy: FM $1630 vs OA $1341; indirect: FM $2913 vs OA $2537, P < 0.0001). Employees with FM had more claims than OA for psychiatric diagnoses, chronic fatigue, and most pain conditions. Use of multiple prescription drug classes was common in both samples. Conclusions: FM imposes significant economic burden. Work loss contributes substantially to the impact.